This video explores how the 1960s transformed the guitar—from the birth of rock icons to groundbreaking innovations in sound, style, and technology that reshaped modern music forever. Hunter found ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. BOSTON — The CEO of the ...

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Emma Walmsley was the first woman to hold the CEO post at ...

GSK plc announces its CEO transition, with CCO Luke Miels to succeed Emma Walmsley, as shares rise 3% and the company maintains a 4% dividend yield. GSK's strengths include its HIV, vaccines, and ...

Miels, GSK's chief commercial officer, to become CEO in January Miels joined GSK in 2017, bringing extensive biopharma experience GSK shares rise over 2% Sept 29 (Reuters) - GSK's (GSK.L), opens new ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke Miels — then an executive at rival AstraZeneca Plc — would be “a dream ...

LONDON — GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker.

The first woman to helm a Big Pharma will be stepping down in January as GSK’s Emma Walmsley moves aside for her chief commercial officer Luke Miels. Walmsley, 56, who became the British pharma’s CEO ...

GSK GSK-0.53%decrease; red down pointing triangle said Chief Executive Emma Walmsley would step down and be succeeded by commercial chief Luke Miels, as the drugmaker works to replenish its product ...